Certificate of Confidentiality

CERTIFICATE OF CONFIDENTIALITY
Number:
CC-OD-19-170
Issued to
Denver Health and Hospital Authority
conducting research known as
Survey of Non-Medical Use of Prescription Drugs (NMU-Rx) in the United States
In accordance with the provisions of section 301(d) of the Public Health Service Act, 42 U.S.C. 241(d), this Certificate
is issued to the Principal Investigator, Dr. Richard Dart and Denver Health and Hospital Authority to protect the privacy
of subjects in the above named research study, which is collecting or using identifiable, sensitive information. If there
is a discrepancy between the terms used in this Certificate and section 301(d), the statutory language will control.
Research data containing identifiable, sensitive information collected during this study initiated on 02/21/2019 (and
concluding on 6/1/2027) is covered by the Certificate. Identifiable, sensitive information protected by the Certificate
and all copies thereof are protected for perpetuity.
The recipient of this Certificate shall comply with all requirements of subsection 301(d) of the Public Health Service
Act.
This Certificate does not represent an endorsement of the research project by the Department of Health and Human
Services. Information collected during the term of the Certificate is protected in perpetuity. However, this Certificate
does not protect information collected from participants enrolled after the term of the Certificate.

4/15/2020
Date

NIH Certificates of Confidentiality Coordinator
Office of Extramural Research
National Institutes of Health

Note: The expiration date on this certificate reflects an automatic one‐year extension granted by NIH for CoCs active as of 
April 15, 2020 as a result of the COVID‐19 public health emergency